Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2020-03-29 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
2019年度审计报告
Regulatory Filings
2020-03-29 Chinese
2019年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2019年度内部控制评价报告' which translates to '2019 Annual Internal Control Evaluation Report'. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2019, including financial and non-financial internal control defects, their identification, and remediation. The content is focused on internal control evaluation rather than full financial statements or audit opinions alone. The document length is 4125 characters, which is relatively short but contains substantive evaluation content rather than just an announcement. This type of report aligns with an Audit Report / Information (AR) category, as it is a standalone internal control evaluation report, not a full annual report or interim report. It is not a certification or announcement but a detailed internal control evaluation report. Therefore, the best classification is AR with high confidence. FY 2019
2020-03-29 Chinese
关于股东股份解除质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by a major shareholder and related parties. It details the number of shares released from pledge, the shareholder's holdings, and the updated pledge status. There is no financial report, earnings data, or management discussion. The content focuses on share pledge status changes, which is a capital structure related update but specifically about share pledge release. This fits best under the category of Capital/Financing Update (CAP), as it relates to financing activities involving share pledges and releases.
2020-03-17 Chinese
关于股东股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by a major shareholder of the company. It details the number of shares released from pledge, the remaining pledged shares, and the shareholding percentages before and after the release. There is no financial statement, earnings data, or management discussion. The document is a regulatory disclosure about share pledge status, which fits the category of Major Shareholding Notification (MRQ) as it involves significant share ownership changes and pledge status updates.
2020-03-13 Chinese
关于子公司取得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company about its subsidiary obtaining a new veterinary drug registration certificate. It details the product, its development, regulatory approval process, and expected market impact. The document is short (1297 characters) and serves as a formal notification rather than a detailed report or financial statement. It does not contain financial data, management discussion, or regulatory certifications. It is not a report publication announcement since it does not mention the release of a report but rather announces a regulatory approval event. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous official announcements that do not fit other specific categories.
2020-03-04 Chinese
关于以集中竞价交易方式回购股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase via centralized bidding transactions. It details the number of shares repurchased, the price range, total amount paid, and compliance with relevant regulations. It is not a full financial report but an update on capital activity related to share buybacks. Therefore, it fits the category of Transaction in Own Shares (POS). The document length and content confirm it is not a report publication or regulatory filing but a specific announcement of share repurchase progress.
2020-03-03 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.